蒽环类药物
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | 3'-deamino-3"-4'-anhydro-[2"(S)-methoxy-3"(R)-hydroxy-4"-morpholinyl] carminomycin | 1377918-01-8 | C31H33NO12 |
| —— | 73991-73-8 | C29H24F3NO11 | |
| —— | Acetic acid (2S,3R,4S,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-2-((1R,2S,3S)-3-acetyl-2,3,5,12-tetrahydroxy-2-methyl-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-tetrahydro-pyran-3-yl ester | 730991-04-5 | C35H36O17 |
| —— | N-(N-oleoyl-glycyl-L-alanyl-L-valyl)-doxorubicin | 1046805-58-6 | C55H78N4O15 |
| —— | 7-[4-O-(3-amino-2,3,6-trideoxy-3-N-allyloxycarbonyl-α-L-lyxo-hexopyranosyl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]-4-demethoxyadriamycinone | 452071-73-7 | C36H41NO14 |
| —— | (7R,9R)-14-O-(tert-butyldimethylsilyl)-4-demethoxy-7-O-(3,4-di-O-acetyl-2,6-dideoxy-2-iodo-α-L-mannopyranosyl)adriamycinone | 92689-47-9 | C36H43IO13Si |
| —— | 3'-deamino-3"-4'-anhydro-[2"(S)-methoxy-3"(R)-hydroxy-4"-morpholinyl] idarubicin | 1377917-97-9 | C31H33NO11 |
| —— | N-Trifluoracetyl-14-ethoxy-daunorubicin | 66678-24-8 | C31H32F3NO12 |
| —— | N-Trifluoracetyl-4-demethoxy-4-isopropoxy-daunorubicin | 67665-70-7 | C31H32F3NO11 |
| —— | N-(N-oleoyl-L-valyl-L-valyl)-doxorubicin | 1046805-52-0 | C55H79N3O14 |
| —— | N-Trifluoracetyl-4-demethoxy-4-alkoxy-Daunorubicin | 67665-78-5 | C34H36F3NO11 |
| —— | N-[(2S,3S,4S,6R)-6-((1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-3-iodo-2-methyl-tetrahydro-pyran-4-yl]-2,2,2-trifluoro-acetamide | 83000-49-1 | C29H27F3INO10 |
| —— | (2'S,3'S,4'S,5'R,6'R)-7-O-<2'-(4',5'-dihydroxy-3'-iodo-6'-phenyltetrahydropyranosyl)>daunomycinone | 138512-04-6 | C32H29IO11 |
| —— | 3-oxo-3-[2-oxo-2-[2,5,12-trihydroxy-4-[5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethoxy]propanoic acid | 97191-43-0 | C32H30F3NO15 |
| —— | N-Trifluoracetyl-4-demethoxy-4-alkoxy-Daunorubicin | 67665-88-7 | C32H34F3NO11 |
| —— | (7S,9R,10R)-7-<<3-(trifluoroacetamido)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl>oxy>-7,8,9,10-tetrahydro-6,9,11-trihydroxy-10-acetoxy-9-methyl-5,12-naphthacenedione | 128243-36-7 | C29H28F3NO11 |
| —— | (+)-(7S,9S)-7-O-(2'-deoxy-β-D-erythro-pentopyranosyl)-11-deoxydaunomycinone | 120189-32-4 | C26H26O10 |
| —— | N-Trifluoracetyl-4-demethoxy-4-alkoxy-Daunorubicin | 67665-98-9 | C32H34F3NO11 |
| —— | 7-O-<4-O-(2,6-didesoxy-α-L-lyxo-hexopyranosyl)-2,3,6-tridesoxy-3-(trifluoroacetamido)-α-L-lyxo-hexopyranosyl>daunomycinone | 82225-08-9 | C35H38F3NO14 |
| —— | Acetic acid (1R,2R,4S)-4-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2,5,12-trihydroxy-2-methyl-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yl ester; hydrochloride | 128243-40-3 | C27H29NO10*ClH |
| —— | 73135-41-8 | C29H28F3NO11 | |
| —— | Hyrubicin | 176665-19-3 | C42H52N2O16 |
| —— | N-(trifluoroacetyl)-14-O-(N-acetylglycyl)adriamycin | 101980-54-5 | C33H33F3N2O14 |
| —— | 7-[4-O-(3-N,4-O-di-allyloxycarbonyl-3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]-4-demethoxyadriamycinone | 452071-74-8 | C40H45NO16 |
| —— | AEC-D-Ala-Phe-Lys-PABC-PABC-Dox hydrochloride | 925893-59-0 | C64H72N10O20*ClH |
| —— | N-demethylnogalamycin | 81163-00-0 | C38H47NO16 |
| —— | (2'S,3'S,4'S,5'R,6'R)-7-O-<2'-(4',5'-dihydroxy-3'-iodo-6'-phenyltetrahydropyranosyl)>daunomycinone | 138407-78-0 | C32H29IO11 |
| —— | 3',4'-demethoxynogalose-nogalamycinone. | 1416135-71-1 | C29H32O12 |
| —— | 136949-03-6 | C36H40O17Si | |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-(2-carboxyl-6-fluoro)benzoate | 1190845-28-3 | C39H34FNO14 |
| —— | 14-iodo-N-(trifluoroacetyl)daunorubicin | 26295-55-6 | C29H27F3INO11 |
| —— | 3'-(pyrido-(2,3)succinimido)doxorubicin-14-oxo-glycinate hydrochloride | 1190845-52-3 | C36H33N3O14*ClH |
| —— | 136949-02-5 | C36H40O17Si | |
| —— | 3'-pyrrolyl-4'-(pyran-2-yl)doxorubicin-14-oxo-glycinate hydrochloride | 1190845-48-7 | C38H42N2O13*ClH |
| —— | 3'-pyrrolyl-4'-(pyran-2-yl)doxorubicin-14-oxo-hydrogen succinate | 1190845-14-7 | C40H43NO15 |
| —— | N-acetyl-N-demethylnogalamycin | 81162-99-4 | C40H49NO17 |
| —— | 929010-90-2 | C31H36N2O10 | |
| —— | (7S,9R,10R)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-ethyl-2,6,9,10-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione | 93524-53-9 | C26H29NO9 |
| —— | 3'-succinimidodoxorubicin-14-oxo-glycinate hydrochloride | 1190845-49-8 | C33H34N2O14*ClH |
| —— | 3'-pyrrolyl-4'-(pyran-2-yl)doxorubicin | 1190845-04-5 | C36H39NO12 |
| —— | oxaunomycin hydrochloride | 128240-71-1 | C26H29NO10*ClH |
| —— | (7S,9R,10R)-7-<(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy>-7,8,9,10-tetrahydro-6,9,11-trihydroxy-10-methoxy-9-methyl-5,12-naphthacenedione | 128243-38-9 | C26H29NO9 |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-2-diethylaminoacetate | 1190845-44-3 | C37H42N2O12 |
| —— | 3'-pyrrolyldoxorubicin-14,4'-oxo-(3-nitro-2-carboxyl)dibenzoate | 1190845-36-3 | C47H37N3O21 |
| —— | N-(ethoxyformyl)-3'-N,4'-O-methylenedaunorubicin | 214896-00-1 | C31H33NO12 |
| —— | (7S,9S)-9-acetyl-7-<(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl)oxy>-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione | 88204-90-4 | C34H34O16 |
| —— | 2',4'-di-O-acetylnogalamycin | 81162-96-1 | C43H53NO18 |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-(3-carboxyl)pyridine-2-formate | 1190845-35-2 | C38H34N2O14 |
| —— | (7S,9S)-(+)-idarubicinone-7-(tetra-O-acetyl)-α-D-glucose | 1232835-30-1 | C34H34O16 |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-β-alaninate hydrochloride | 1190845-54-5 | C34H36N2O12*ClH |
联系我们
关注我们
公众号
